This Plain Language Summary of Publication article (PLSP) from Future Neurology examined lemborexant, a DORA medication for insomnia treatment, to assess its potential for abuse using the US Controlled Substances Act’s 8-factor analysis. Since lemborexant affects the central nervous system like other sleep medications, researchers evaluated whether it poses risks for misuse or dependency by analyzing eight specific safety factors to determine its abuse potential in patients with sleep disorders.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act’ and was published in Psychopharmacology.

Visit Springer Nature using the link to read the original article.